X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 29,055 | 19,119 | 18,997 | 17,936 | 17,655 |
| Operating Income | -29,055 | -19,119 | -18,997 | -17,936 | -17,655 |
| Interest Expense | 926 | 920 | 905 | 891 | 720 |
| Other Income | -223 | -134 | 270 | 157 | -25 |
| Pre-tax Income | -30,204 | -20,173 | -19,632 | -18,670 | -18,400 |
| Income Tax | 3 | 2 | 6 | 6 | N/A |
| Net Income Continuous | -30,207 | -20,175 | -19,638 | -18,676 | -18,400 |
| Net Income | $-30,207 | $-20,175 | $-19,638 | $-18,676 | $-18,400 |
| EPS Basic Total Ops | -35.74 | -22.82 | -22.22 | -39.04 | -27.03 |
| EPS Basic Continuous Ops | -31.42 | -22.77 | -22.23 | -27.03 | -27.43 |
| EPS Diluted Total Ops | -35.74 | -22.82 | -22.22 | -39.04 | -27.03 |
| EPS Diluted Continuous Ops | -31.42 | -22.77 | -22.23 | -27.03 | -27.43 |
| EBITDA(a) | $-19,165 | $-18,987 | $-18,868 | $-17,830 | $-17,552 |